Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence

BACKGROUND: The treatment of methamphetamine dependence is a continuing global health problem. Agonist type pharmacotherapies have been used successfully to treat opioid and nicotine dependence and are being studied for the treatment of methamphetamine dependence. One potential candidate is lisdexam...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezard, Nadine, Dunlop, Adrian, Clifford, Brendan, Bruno, Raimondo, Carr, Andrew, Bissaker, Alexandra, Lintzeris, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134059/
https://www.ncbi.nlm.nih.gov/pubmed/27905916
http://dx.doi.org/10.1186/s12888-016-1141-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134059/
https://www.ncbi.nlm.nih.gov/pubmed/27905916
http://dx.doi.org/10.1186/s12888-016-1141-x

Ejemplares similares